96 related articles for article (PubMed ID: 3260342)
1. Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease.
Rinne UK
Mt Sinai J Med; 1988 Mar; 55(2):138-41. PubMed ID: 3260342
[No Abstract] [Full Text] [Related]
2. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
Olsson JE
Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483
[No Abstract] [Full Text] [Related]
4. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
[TBL] [Abstract][Full Text] [Related]
5. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A
Eur Neurol; 1988; 28 Suppl 1():3-8. PubMed ID: 3378560
[TBL] [Abstract][Full Text] [Related]
6. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
7. Early dopamine agonist treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1990; 53():417-9. PubMed ID: 1978520
[No Abstract] [Full Text] [Related]
8. Bromocriptine and lisuride in Parkinson's disease.
Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
[No Abstract] [Full Text] [Related]
9. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
10. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Dufresne JJ
Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
[No Abstract] [Full Text] [Related]
12. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
13. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
14. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Olsson JE; Duchek M; Ekberg R; Fehling C; Johansson F; Johnels B; Lindvall B; Nordin G; Sidén A; Steg G
Lakartidningen; 1993 Apr; 90(16):1545-8. PubMed ID: 8483351
[No Abstract] [Full Text] [Related]
15. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Peiró Grasa A; Grau-Veciana JM
Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
[No Abstract] [Full Text] [Related]
16. [Combination treatment in the early stages of Parkinson's disease].
Johnels B
Nord Med; 1987; 102(1):22-3. PubMed ID: 3822792
[No Abstract] [Full Text] [Related]
17. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Zimmerman TR; Sage JI; Lang AE; Mark MH
Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
[TBL] [Abstract][Full Text] [Related]
18. Ropinirole therapy for Parkinson's disease.
Pahwa R; Lyons KE; Hauser RA
Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
[TBL] [Abstract][Full Text] [Related]
19. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
20. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
